Combined chemotherapeutic and photodynamic treatment on human bladder cells by hematoporphyrin-platinum(II) conjugates.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Letters

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.CANLET.2003.09.001PMID 14732225
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Different response of murine and human mammary tumour models to a series of diastereoisomeric [1,2-bis(difluorophenyl) ethylenediamine]dichloroplatinum(II) complexes

  2005cited by this paper
• Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity

  2005cited by this paper
• Immortalisation of human urothelial cells

  2004cited by this paper
• Hematoporphyrin-derived soluble porphyrin-platinum conjugates with combined cytotoxic and phototoxic antitumor activity.

  2002cited by this paper
• The present and future of combination chemotherapy in bladder cancer.

  2002cited by this paper
• Biodistribution and Bioactivity of Tetra‐pegylated Meta‐tetra(hydroxyphenyl)chlorin Compared to Native Meta‐tetra(hydroxyphenyl)chlorin in a Rat Liver Tumor Model

  2000cited by this paper
• [meso‐1,2‐Bis(2,6‐dichloro‐4‐hydroxyphenyl)ethylenediamine]sulfato‐platinum(II) — Pharmacokinetic Studies

  1999cited by this paper
• Highly Selective Targeting of Ovarian Cancer with the Photosensitizer PEG‐m‐THPC in a Rat Model

  1999cited by this paper
• Photodynamic therapeutics: basic principles and clinical applications.

  1999cited by this paper
• Oxaliplatin: a review of preclinical and clinical studies.

  1998cited by this paper
• Ongoing and unsaid on oxaliplatin: the hope.

  1998cited by this paper
• Dosedependent photodynamic effects of 9-acetoxy-2,7,12,17-tetrakis(\-methoxyethyl)-porphycene in vitro

  1997cited by this paper
• [Oxaliplatin: the first DACH platinum in clinical practice].

  1997cited by this paper
• Computerized determination of growth kinetic curves and doubling times from cells in microculture.

  1990cited by this paper
• Photodynamic Therapy

  1988cited by this paper

• Synthesis and evaluation of the combined chemotherapeutic and photodynamic action of new Pt-complexes of natural chlorins.

  2026cites this paper
• Synergistic Cancer treatment strategies using platinum-porphyrin conjugates

  2025cites this paper
• Advantages of combined photodynamic therapy in the treatment of oncological diseases

  2022cites this paper
• Porphyrins and Metalloporphyrins Combined with N-Heterocyclic Carbene (NHC) Gold(I) Complexes for Photodynamic Therapy Application: What Is the Weight of the Heavy Atom Effect?

  2022cites this paper
• Potential Application of Photosensitizers With High-Z Elements for Synergic Cancer Therapy

  2022cites this paper
• Photodynamic Therapy for Bladder Cancers, A Focused Review †

  2022cites this paper
• Conjugates of Porphyrinoid-Based Photosensitizers with Cytotoxic Drugs: Current Progress and Future Directions toward Selective Photodynamic Therapy.

  2022cites this paper
• Supramolecular Self-Assembly of Porphyrin and Metallosurfactant as a Drug Nanocontainer Design

  2022cites this paper
• In vitro toxicity and photodynamic properties of porphyrinoids bearing imidazolium salts and N-heterocyclic carbene gold(I) complexes

  2021cites this paper
• Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer

  2021cites this paper
• Potent PBS/Polysorbate-Soluble Transplatin-Derived Porphyrin-Based Photosensitizers for Photodynamic Therapy.

  2021cites this paper
• Applying Cu(II) complexes assisted by water‐soluble porphyrin to DNA binding and selective anticancer activities

  2020cites this paper
• Magnetic anisotropy in 5d transition metal–porphyrin molecules

  2020cites this paper
• A promising anticancer drug: a photosensitizer based on the porphyrin skeleton.

  2020cites this paper
• Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies

  2019cites this paper
• Nanoparticles‐Mediated Combination Therapies for Cancer Treatment

  2019cites this paper
• Peripherally Metalated Porphyrins with Applications in Catalysis, Molecular Electronics and Biomedicine.

  2018cites this paper
• Photoactivated platinum-based anticancer drugs

  2018cites this paper
• Cellular Pharmacology of Palladinum(III) Hematoporphyrin IX Complexes: Solution Stability, Antineoplastic and Apoptogenic Activity, DNA Binding, and Processing of DNA-Adducts

  2018cites this paper
• Cancer therapies: applications, nanomedicines and nanotoxicology

  2017cites this paper
• Synergistic Effects in PtII -Porphyrinoid Dyes as Candidates for a Dual-Action Anticancer Therapy: A Theoretical Exploration.

  2017cites this paper
• Iodinated chlorin p6 copper complex induces anti-proliferative effect in oral cancer cells through elevation of intracellular reactive oxygen species.

  2017cites this paper
• Engineering of relevant photodynamic processes through structural modifications of metallotetrapyrrolic photosensitizers

  2016cites this paper
• Metal-based drugs that break the rules.

  2016cites this paper
• A TDDFT Computational Study of Platinum Complexes Bound to Nucleobases

  2016cites this paper
• Photodynamic Efficiency: From Molecular Photochemistry to Cell Death

  2015cites this paper
• Image-guided combination chemotherapy and photodynamic therapy using a mitochondria-targeted molecular probe with aggregation-induced emission characteristics† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c5sc00826c Click here for additional data file.

  2015cites this paper
• Targeted photoresponsive TiO2–coumarin nanoconjugate for efficient combination therapy in MDA-MB-231 breast cancer cells: synergic effect of photodynamic therapy (PDT) and anticancer drug chlorambucil

  2015cites this paper
• Interactions of DNA with H2TMPyP4+and Ru(II)TMPyP4+: Probable Lead Compounds for African Sleeping Sickness

  2015cites this paper
• Phototoxic Activity and DNA Interactions of Water‐Soluble Porphyrins and Their Rhenium(I) Conjugates

  2015cites this paper
• Photophysicochemical behavior and antimicrobial activity of dihydroxosilicon tris(diaquaplatinum)octacarboxyphthalocyanine.

  2014cites this paper
• Novel amphiphilic cationic porphyrin and its Ag(II) complex as potential anticancer agents.

  2014cites this paper
• Advance in Photosensitizers and Light Delivery for Photodynamic Therapy

  2013cites this paper
• Pyrazinoporphyrazines with externally appended pyridine rings. 13. Structure, UV-visible spectral features, and noncovalent interaction with DNA of a positively charged binuclear (Zn(II)/Pt(II)) macrocycle with multimodal anticancer potentialities.

  2013cites this paper
• Phenylacetylide ligand mediated tuning of visible-light absorption, room temperature phosphorescence lifetime and triplet–triplet annihilation based up-conversion of a diimine Pt(II) bisacetylide complex

  2013cites this paper
• Targeting strategies in photodynamic therapy for cancer treatment

  2013cites this paper
• Tetra-2,3-pyrazinoporphyrazines with externally appended pyridine rings. 12. New heteropentanuclear complexes carrying four exocyclic cis-platin-like functionalities as potential bimodal (PDT/cis-platin) anticancer agents.

  2012cites this paper
• Systems biology approach for in vivo photodynamic therapy optimization of ruthenium-porphyrin compounds.

  2012cites this paper
• A zinc(II) phthalocyanine conjugated with an oxaliplatin derivative for dual chemo- and photodynamic therapy.

  2012cites this paper
• Drug targeting strategies for photodynamic therapy.

  2012cites this paper
• Photoimmunotherapy and irradiance modulation reduce chemotherapy cycles and toxicity in a murine model for ovarian carcinomatosis: perspective and results.

  2012cites this paper
• Tuning photophysics and nonlinear absorption of bipyridyl platinum(II) bisstilbenylacetylide complexes by auxiliary substituents.

  2012cites this paper
• Tetra-2,3-pyrazinoporphyrazines with externally appended pyridine rings: 11 Photoactivity of a new Pt(II) pentanuclear macrocycle bearing four cisplatin-like functionalities and its related monoplatinated species

  2011cites this paper
• Tetra-2,3-pyrazinoporphyrazines with externally appended pyridine rings. 9. Novel heterobimetallic macrocycles and related hydrosoluble hexacations as potentially active photo/chemotherapeutic anticancer agents.

  2011cites this paper
• In vitro pharmacological study of monomeric platinum(III) hematoporphyrin IX complexes

  2011cites this paper
• Mechanisms of resistance to photodynamic therapy.

  2011cites this paper
• Development of the synthesis of the diamine complexes of covalent conjugates of platinum(II) with octacarboxy-substituted cobalt phthalocyanine

  2011cites this paper
• Efficient synthesis and in vitro photodynamic anticancer study of new purpurinimide-hydrazone conjugates

  2011cites this paper
• Enhancing Photodynamyc Therapy Efficacy by Combination Therapy: Dated, Current and Oncoming Strategies

  2011cites this paper
• Targeted and multifunctional arene ruthenium chemotherapeutics.

  2011cites this paper
• Interaction studies between a 1,10-phenanthroline adduct of palladium(II) dithiocarbamate anti-tumor complex and calf thymus DNA. A synthesis spectral and in-vitro study.

  2010cites this paper
• A categorization of metal anticancer compounds based on their mode of action.

  2009cites this paper
• Synthetic strategies towards ruthenium-porphyrin conjugates for anticancer activity.

  2009cites this paper
• Sawhorse-type diruthenium tetracarbonyl complexes containing porphyrin-derived ligands as highly selective photosensitizers for female reproductive cancer cells

  2009cites this paper
• In Vitro Evaluation of a Stable Monomeric Gold(II) Complex with Hematoporphyrin IX: Cytotoxicity against Tumor and Kidney Cells, Cellular Accumulation, and Induction of Apoptosis

  2008cites this paper
• GGA + U modeling of structural, electronic, and magnetic properties of iron porphyrin-type molecules

  2008cites this paper
• Ruthenium porphyrin compounds for photodynamic therapy of cancer.

  2008cites this paper
• Combination of photodynamic therapy with anti-cancer agents.

  2008cites this paper
• Pharmacokinetics, tissue distribution and excretion of a new photodynamic drug deuxemether.

  2008cites this paper
• Combined arene ruthenium porphyrins as chemotherapeutics and photosensitizers for cancer therapy

  2008cites this paper
• Interaction of an Fe derivative of TMAP (Fe(TMAP)OAc) with DNA in comparison with free-base TMAP.

  2007cites this paper
• Recent developments in antitumour platinum coordination compounds

  2006cites this paper
• Peptide-mediated cell transport of water soluble porphyrin conjugates.

  2006cites this paper
• Head and Neck

  2005cites this paper
• RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid–induced protoporphyrin IX in vitro

  2005cites this paper
• Bioinorganic photochemistry: frontiers and mechanisms.

  2005cites this paper
• Distribution and subcellular localization of a water-soluble hematoporphyrin-platinum(II) complex in human bladder cancer cells.

  2004cites this paper
• Mild and selective reduction of imines: formation of an unsymmetrical macrocycle.

  2004cites this paper